Unique effects of carvedilol on noradrenaline release in the human heart.
Richardt
G
G
Universitätsklinikum Lübeck, Medizinische Klinik II, Ratzeburger Allee 160, 23538, Lübeck, Germany. gert.richardt@medinf.mu-luebeck.de
Richardt
D
D
Adler
S
S
Kraatz
E
E
Nötzold
A
A
Kurz
T
T
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D017298:Bisoprolol / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects*; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism*; D011412:Propanolamines / Q000627:therapeutic use*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D008790:Metoprolol; D009638:Norepinephrine; D017298:Bisoprolol